Skip to content

The efficacy of remote ischemic preconditioning training on improving post-stroke insomnia: a randomized controlled trial

The effect of remote ischemic preconditioning training on improving post-stroke sleep disorders: a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087429
Enrollment
Unknown
Registered
2024-07-26
Start date
2024-08-01
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-stroke insomnia

Interventions

Control group:Routine nursing practice, give patients a good sleep environment and sleep guidance.
Intervention group:he ischemic preconditioning device (model: IPC-906) developed by Xuanyitong was used to pressurize the two upper limbs to 200mmHg at the same time, block the distal blood flow of th

Sponsors

Beijing Shijitan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. The participants must fulfill the diagnostic criteria outlined in the "Guidelines for the Diagnosis and Treatment of Acute Ischemic Stroke in China (Second Edition)" or the "Guidelines for the Diagnosis and Treatment of Intracerebral Hemorrhage in China (2023)", with confirmation of ischemic or hemorrhagic lesions through imaging examination. 2. The participants must meet the diagnostic criteria for insomnia as stipulated in the "Diagnostic and Treatment Guidelines for Adult Insomnia in China (2017 Edition)", or have a Pittsburgh Sleep Quality Index score =7. 3. The age range of 35 to 75 years. 4. The participants are required to provide informed consent, demonstrate willingness to cooperate, and be capable of completing the research cycle. 5. Have no language communication barriers.

Exclusion criteria

Exclusion criteria: 1. Patients with insomnia before stroke; 2. Those who are regularly taking sedative and hypnotic drugs (frequency =3 times/week); 3. Patients with consciousness disorder in acute stage of cerebral hemorrhage; 4. Patients with thrombi or unstable lipid plaque in both upper limbs, soft tissue injury, limb deformity and vascular injury in upper limbs, and patients with bleeding disease and systolic blood pressure over 200 mmHg; 5. Patients with severe heart, brain and renal dysfunction; 6. Heart rate > 100 /min, or < 50 /min.

Design outcomes

Primary

MeasureTime frame
Improvement of patients' sleep quality;

Secondary

MeasureTime frame
Improvement of quality of life after stroke;Improvement of anxiety symptoms;Patient tolerance and safety of ischemic preconditioning techniques during intervention;Patients' subjective feeling of improved sleep quality;

Countries

China

Contacts

Public ContactBeibei Duan

Beijing Shijitan Hospital, Capital Medical University

731000063@qq.com+86 188 0018 9567

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026